Clinical Trials Directory

Trials / Completed

CompletedNCT06165445

Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder

Optimized Multichannel tDCS Protocol vs Conventional and Sham tDCS for Clinical Use in Patients With Major Depressive Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
The National Brain Mapping Laboratory (NBML) · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

In this project, the efficacy of different tDCS protocols in major depression will be investigated. The tDCS protocols have already been investigated in humans, and results showed that stimulation intensity has a different effect on tDCS long-term aftereffects based on the human motor cortex model. The project has three major goals: first, we want to see if the differential outcome of tDCS dosage, as present in healthy populations, can be translated to patients with major depression. Second, we want to compare the efficacy of a multi-channel novel protocol with conventional tDCS modules. Lastly, we are interested in the safety and tolerability of optimized multi-channel. The project output will be an optimized tDCS protocol for major depression treatment.

Conditions

Interventions

TypeNameDescription
DEVICEtranscranial direct current stimulation (tDCS)In tDCS, direct electrical currents at the intensity of interest (2 mA for example) are generated by an electrical stimulator and are noninvasively delivered to the scalp through a pair of saline-soaked sponge electrodes (7×5 cm) or via more than two but smaller round electrodes over the target regions.
DEVICEmultichannel transcranial direct current stimulation (tDCS)In multichannel tDCS, direct electrical currents at the intensity of interest (2 mA for example) are generated by an electrical stimulator and are noninvasively delivered to the scalp through more than two and smaller round electrodes over the target regions.

Timeline

Start date
2021-06-01
Primary completion
2022-12-01
Completion
2023-03-01
First posted
2023-12-11
Last updated
2026-03-18

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT06165445. Inclusion in this directory is not an endorsement.

Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder (NCT06165445) · Clinical Trials Directory